You just read:

Clene Nanomedicine Announces First Patient Enrolled in the REPAIR-PD Clinical Trial for the Treatment of Parkinson's Disease with the Nanocatalytic Therapeutic, CNM-Au8

News provided by

Clene Nanomedicine, Inc.

Dec 03, 2019, 08:00 ET